Biologique Croissance Technologies Private Limited
Provides software design, development, customization, implementation, maintenance, testing, and distribution services.
2020 | Delhi (India) | Active
Biologique Croissance Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 1.00 K
- Company Age 4 Year, 7 Months
About Biologique Croissance Technologies
Biologique Croissance Technologies Private Limited (BCTPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 July 2020 (Four years and seven months 23 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 1.00 K , as per Ministry of Corporate Affairs (MCA) records.
Divya and Ravi Jha serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U72900DL2020PTC365696
- Company No.
365696
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2020
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Information Technology
Who are the key members and board of directors at Biologique Croissance Technologies?
Board Members (2)
Financial Performance of Biologique Croissance Technologies.
Enhance accessibility to Biologique Croissance Technologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biologique Croissance Technologies?
Unlock access to Biologique Croissance Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Atencion Libre Technologies Private Limited
Divya is a mutual person
- White Esprit Technologies Private Limited
Divya is a mutual person
- Harmonie Libre Technologies Private Limited
Ravi Jha is a mutual person
- Excelencia Pleno Technologies Private Limited
Ravi Jha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biologique Croissance Technologies?
Biologique Croissance Technologies has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biologique Croissance Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biologique Croissance Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
